The Journal of Allergy and Clinical Immunology
Volume 128, Issue 3 , Pages 618-625.e7, September 2011

Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes

  • Stephanie Brand, PhD

      Affiliations

    • Department of Clinical Chemistry and Molecular Diagnostics, Philipps University of Marburg, Marburg, Germany
    • These authors contributed equally to this work.
  • ,
  • René Teich, PhD

      Affiliations

    • Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany
    • These authors contributed equally to this work.
  • ,
  • Tanja Dicke, PhD

      Affiliations

    • Department of Clinical Chemistry and Molecular Diagnostics, Philipps University of Marburg, Marburg, Germany
  • ,
  • Hani Harb, BSc

      Affiliations

    • Department of Clinical Chemistry and Molecular Diagnostics, Philipps University of Marburg, Marburg, Germany
  • ,
  • Ali Ö. Yildirim, MD

      Affiliations

    • Comprehensive Pneumology Centre, Institute of Lung Biology and Disease, Helmholtz Centre Munich, Neuherberg, Germany
  • ,
  • Jörg Tost, PhD

      Affiliations

    • Laboratory for Epigenetics, Centre National de Génotypage, CEA–Institut de Génomique, Evry, France
    • Laboratory for Functional Genomics, Fondation Jean Dausset–CEPH, Paris, France
  • ,
  • Regine Schneider-Stock, PhD

      Affiliations

    • Experimental Tumor Pathology, Institute of Pathology, University of Erlangen-Nuernberg, Erlangen, Germany
  • ,
  • Robert A. Waterland, PhD

      Affiliations

    • Departments of Pediatrics and Molecular and Human Genetics, Baylor College of Medicine, USDA Children’s Nutrition Research Center, Houston, Tex
  • ,
  • Uta-Maria Bauer, PhD

      Affiliations

    • Institute of Molecular Biology and Tumor Research (IMT), Philipps University of Marburg, Marburg, Germany
  • ,
  • Erika von Mutius, MD, MSc

      Affiliations

    • University Children’s Hospital, Ludwig-Maximilians-Universiät, Munich, Germany
  • ,
  • Holger Garn, PhD

      Affiliations

    • Department of Clinical Chemistry and Molecular Diagnostics, Philipps University of Marburg, Marburg, Germany
    • These authors contributed equally to this work.
  • ,
  • Petra I. Pfefferle, PhD, DrPH

      Affiliations

    • Department of Clinical Chemistry and Molecular Diagnostics, Philipps University of Marburg, Marburg, Germany
    • These authors contributed equally to this work.
  • ,
  • Harald Renz, MD

      Affiliations

    • Department of Clinical Chemistry and Molecular Diagnostics, Philipps University of Marburg, Marburg, Germany
    • These authors contributed equally to this work.
    • Corresponding Author InformationReprint requests: Harald Renz, MD, Department of Clinical Chemistry and Molecular Diagnostics Medical Faculty, Philipps University of Marburg, Baldingerstraße 1, 35043 Marburg, Germany.

Received 30 September 2010; received in revised form 19 April 2011; accepted 22 April 2011. published online 16 June 2011.

Article Outline

Background

Bronchial asthma is a chronic inflammatory disease resulting from complex gene-environment interactions. Natural microbial exposure has been identified as an important environmental condition that provides asthma protection in a prenatal window of opportunity. Epigenetic regulation is an important mechanism by which environmental factors might interact with genes involved in allergy and asthma development.

Objective

This study was designed to test whether epigenetic mechanisms might contribute to asthma protection conferred by early microbial exposure.

Methods

Pregnant maternal mice were exposed to the farm-derived gram-negative bacterium Acinetobacter lwoffii F78. Epigenetic modifications in the offspring were analyzed in TH1- and TH2-relevant genes of CD4+ T cells.

Results

Prenatal administration of A lwoffii F78 prevented the development of an asthmatic phenotype in the progeny, and this effect was IFN-γ dependent. Furthermore, the IFNG promoter of CD4+ T cells in the offspring revealed a significant protection against loss of histone 4 (H4) acetylation, which was closely associated with IFN-γ expression. Pharmacologic inhibition of H4 acetylation in the offspring abolished the asthma-protective phenotype. Regarding TH2-relevant genes only at the IL4 promoter, a decrease could be detected for H4 acetylation but not at the IL5 promoter or the intergenic TH2 regulatory region conserved noncoding sequence 1 (CNS1).

Conclusion

These data support the hygiene concept and indicate that microbes operate by means of epigenetic mechanisms. This provides a new mechanism in the understanding of gene-environment interactions in the context of allergy protection.

Key words: Asthma, allergy, epigenetics, histone acetylation, hygiene hypothesis, T cells

Abbreviations used: BAL, Bronchoalveolar lavage, CFSE, Carboxyfluorescein succinimidyl ester, ChIP, Chromatin immunoprecipitation, CNS1, Conserved noncoding sequence 1, H3K27me3, Trimethylated lysine 27 of histone 3, H4, Histone 4, H4ac, Acetylated histone 4, MNC, Mononuclear cell, OVA, Ovalbumin

 

Discuss this article on the JACI Journal Club blog: www.jaci-online.blogspot.com.

Allergic bronchial asthma is a multifactorial disorder of the lung initiated by both genetic and environmental factors.1 Epigenetic regulation represents one important mechanism by which environmental factors might interact with genes involved in allergy and asthma development.2 Although it has been shown that DNA methylation and histone modification might have a crucial role in the underlying processes of development and differentiation of T-cell subsets, including TH1 and TH2 cells,3 the detailed molecular and cellular nature of this relationship in asthma initiation or prevention remains to be uncovered.4

Recently, the concept of epigenetic regulation in asthma development has gained increasing attention.5 In particular, transplacental effects are within the focus of current research because microbial exposure in early life, being prevalent in farm settings, is linked to asthma protection at a later stage.6, 7 Various microbial isolates and compounds were recently identified to exhibit an allergoprotective capacity.8, 9, 10, 11, 12, 13 In essence, we find substantial differences between several microbes in terms of influence phenotype development in asthma models. Of these bacterial strains and components, the gram-negative farm-derived isolate Acinetobacter lwoffii F78 was shown to provide the strongest allergoprotective effect in a prenatal model of transmaternal experimental asthma protection (see Table E1 in this article’s Online Repository at www.jacionline.org) and was therefore chosen for further mechanistic studies. First mechanistic studies have shown that transfer of allergoprotective effects is dependent on maternal Toll-like receptor signaling.13 In this study we hypothesized that maternal exposure to A lwoffii F78 during gestation might result in epigenetic regulation of immune response genes in CD4+ T cells in the offspring. To test this hypothesis, we used a well-established animal model of developmental asthma protection and examined possible changes in DNA methylation and histone modifications within the genomic regions of TH1 and TH2 cytokine genes after maternal exposure to A lwoffii F78.

Back to Article Outline

Methods 

Animals 

Six- to 8-week-old female BALB/c mice and BALB/cscid mice were obtained from Harlan Winkelmann (Borchen, Germany). Mice were kept under specific pathogen-free housing conditions. Water and an ovalbumin (OVA)–free diet were supplied ad libitum. All animal experiments were performed in accordance with German and international guidelines and were approved by local authorities (Regierungspraesidium Giessen).

Preparation of A lwoffii F78 

A lwoffii F78 was grown and cultured as described previously.8 Living bacteria were washed in PBS and lyophilized. Lyophilized bacteria were shown to generate living colonies after reconstitution in PBS.

Prenatal A lwoffii F78 exposure 

According to protocols previously optimized for microbial concentration and timing of treatment,10, 11, 13 female BALB/c mice received intranasal applications of 108 colony-forming units of freeze-dried A lwoffii F78 reconstituted in a final volume of 50 μL of PBS 11, 9, 6, 4, and 2 days before mating, as well as every other day during the 3 weeks of pregnancy. Offspring did not receive any A lwoffii F78 supplementation, and A lwoffii DNA could not be detected in the lungs of offspring at the day of analysis. Age-matched control animals were sham treated with PBS.

Sensitization and challenge of offspring 

At the age of 4 weeks, offspring of PBS (control)– or A lwoffii F78–exposed mothers were sensitized to OVA by means of 2 intraperitoneal injections of 10 μg of OVA (grade VI; Sigma, St Louis, Mo) emulsified in 1.5 mg of Al(OH)3 (Pierce, Cheshire, United Kingdom) in a total volume of 200 μL at days 25 and 39 of the experimental protocol. Sham-treated groups received PBS with Al(OH)3. At days 44, 45, and 46, animals were exposed to aerosolized OVA (1% wt/vol diluted in PBS) for 20 minutes. Lung function was analyzed 24 hours after the last aerosol challenge, and another 24 hours later, mice were terminally anesthetized with ketamine plus xylazine for further analyses.

Treatment with anti–IFN-γ mAb 

Offspring mice received intravenous injections of a neutralizing monoclonal rat IgG anti-mouse IFN-γ antibody (100 μg in 100 μL of PBS per mouse and treatment; MAB 485; R&D Systems, Minneapolis, Minn) on the day before and 30 minutes before each OVA aerosol challenge. Control animals received the same amount of IgG from rat serum antibody (control, Sigma).14

Garcinol treatment 

Mice received intraperitoneal injections of the histone acetyltransferase inhibitor garcinol (Enzo Life Sciences, Plymouth Meeting, Pa) at a concentration of 0.2 mg/kg body weight 1 day before and 30 minutes before each OVA aerosol challenge. For additional details, see the Methods section in this article’s Online Repository at www.jacionline.org.

Assessment of airway reactivity 

Lung function analysis was performed 24 hours after the last aerosol challenge by using noninvasive head-out body plethysmography, as previously described.15 Additional details on the methods used are provided in this article’s Online Repository.

Measurement of antibody titers 

Blood samples were taken from the maxillary vessels, and serum levels of anti-OVA IgE, anti-OVA IgG1, and anti-OVA IgG2a were measured by means of ELISA, as previously described.10

Bronchoalveolar lavage and differential cell counts 

Bronchoalveolar lavage (BAL) was performed, as described previously,16 with the exception that lavage was performed only once with a volume of 1 mL. Additional details on the methods are provided in this article’s Online Repository.

Lung histology and quantitative morphologic analysis of mucin production 

Fixed lung tissues were embedded into paraffin, and 3-μm sections were stained with periodic acid–Schiff for determination of goblet cell metaplasia. Additional details on the methods are provided in this article’s Online Repository.

Preparation and stimulation of mononuclear cells 

Spleens were meshed through a nylon sieve, followed by density gradient centrifugation (Pancoll; PAN-Biotech, Bayern, Germany) to obtain mononuclear cells (MNCs). MNCs (1 × 106 cells/well) were stimulated with anti-CD3 (0.5 μg/mL) and anti-CD28 (2 μg/mL) mAbs (BD, Franklin Lakes, NJ). After 24 hours, cell-free supernatants were harvested by means of centrifugation (300g for 10 minutes), and cytokine levels were assessed by means of ELISA.

Measurements of cytokines 

Cell-culture supernatants were analyzed for IL-4, IL-5, IL-10, IFN-γ (Opteia Kit; BD PharMingen, San Jose, Calif), and IL-13 production (CytoSet; Invitrogen, Carlsbad, Calif) by using the ELISA technique. Assays were performed as recommended by the manufacturers.

Measurement of proliferation 

Proliferation measurement of MNCs and CD4+ T cells was performed with carboxyfluorescein succinimidyl ester (CFSE; Molecular Probes, Eugene, Ore), according to the manufacturer’s instructions. Additional details on the methods are provided in this article’s Online Repository.

Quantitative PCR 

Total RNA of isolated CD4+CD25 T cells was extracted (TriFast; Peqlab, Erlangen, Germany) and reverse transcribed (Omniscript RT Kit; Qiagen, Hilden, Germany) by using oligo (dT) primer. A RotorGene (Corbett Life Sciences Qiagen) and the QuantiTect SYBR Green PCR Kit (Qiagen) were used for quantitative real-time PCR of IL4, IL5, IL10, IL13, IFNG, and CD3d (housekeeping control gene). Quantitative PCR data were analyzed according to the previously described 2−(ΔΔCt) method17 and normalized to CD3 gene transcript levels. Primer sequences are detailed in Table E2 in this article’s Online Repository at www.jacionline.org.

Preparation and bisulfite conversion of genomic DNA, PCR, and pyrosequencing 

CD4+CD25 T cells were isolated from splenic MNCs by using MACS, as recommended by the manufacturer (Miltenyi Biotec, Bergisch Gladbach, Germany). Bisulfite conversion of genomic DNA was performed as described elsewhere.18 Template preparation was performed as described previously by Tost and Gut.19 Pyrosequencing was performed with the PyroMark ID System (Biotage AB, Uppsala, Sweden) and sequencing primers. Primer sequences are shown in Table E2. Additional details on the methods are provided in this article’s Online Repository.

Chromatin immunoprecipitation 

CD4+CD25 T cells were isolated from splenic MNCs by using MACS, as recommended by the manufacturer (Miltenyi Biotec). DNA-protein interactions in isolated cells were cross-linked in the presence of 1% formaldehyde for 10 minutes at room temperature. Subsequently, chromatin immunoprecipitation (ChIP) was performed, as described previously,20 with antibodies against acetylated H4 (H4ac; Upstate Biotechnology, Charlottesville, Va) and trimethylated lysine 27 of histone 3 (H3K27me3; Abcam, Cambridge, United Kingdom). Immunoprecipitated and eluted DNA was purified with QIAquick columns (Qiagen) and amplified by means of quantitative PCR. Primer sequences are shown in Table E2. All amplifications were performed in duplicate by using 2 μL of DNA per reaction. The duplicate mean values were displayed as the percentage of immunoprecipitated DNA compared with total DNA (100% input), and the SE was calculated. Control ChIP was performed with a control antibody (rabbit IgG, Sigma) to ensure specificity (data not shown).

Statistical analysis 

The number of independently performed experiments is mentioned in the legend of each figure. All numeric data are expressed as means ± SEs and analyzed for significance by using 3-factor ANOVA with the factors maternal A lwoffii F78 exposure, sensitization of the offspring, and garcinol treatment and by using Tukey analysis or the Student unpaired t test with P values of less than .05, less than .01, and less than .001. Calculations were performed by use of GraphPad Prism software, version 4.01 (GraphPad Software Inc, La Jolla, Calif).

Back to Article Outline

Results 

Asthma-protective effects by prenatal A lwoffii F78 exposure are associated with altered IFN-γ production 

Protection from the development of an asthmatic phenotype by prenatal A lwoffii F78 exposure was accompanied by a marked shift in the TH1/TH2 cytokine profile (Fig 1). In offspring mice from A lwoffii F78–exposed mothers, T-cell in vitro stimulation of splenic MNCs revealed a significantly reduced capability to produce the TH2 cytokines IL-4, IL-5, and IL-13. In contrast, the IFN-γ responsiveness was completely restored in these animals, whereas IL-10 production remained unaffected. Analysis of mRNA cytokine expression in anti-CD3/anti-CD28–stimulated CD4+CD25 T cells confirmed these results. Furthermore, no differences were detected in CD4+CD25+ forkhead box protein 3–positive regulatory T-cell numbers in the progeny by means of FACS analysis (data not shown).

  • View full-size image.
  • Fig 1. 

    TH1/TH2 cytokine balance after prenatal A lwoffii F78 exposure. A, Concentrations of IFN-γ, IL-4, IL-5, IL-13, and IL-10 in the supernatant of anti-CD3/anti-CD28–stimulated mononuclear spleen cells from offspring from A lwoffii F78– or sham-exposed (PBS) mothers. B, Relative mRNA expression of IFN-γ, IL-4, IL-5, IL-13, and IL-10 in CD4+CD25 splenic T cells. Data represent the results of 2 independent experiments, each with 4 to 8 individually analyzed animals per group. ∗P < .05, ∗∗P < .01.

We examined whether the reduced TH2 response might be the result of the restored IFN-γ production in the progeny because IFN-γ counterregulates many TH2 cell activities21, 22 (Fig 1). Therefore IFN-γ function was blocked by treating offspring of A lwoffii F78–exposed mothers with a neutralizing anti–IFN-γ mAb. This treatment completely abolished the A lwoffii F78–mediated effect, as evidenced by restored airway inflammation, goblet cell metaplasia, and development of airway hyperreactivity (Fig 2, A-C). Concurrently, functional blockade of IFN-γ resulted in significantly increased production of the TH2 cytokines IL-4, IL-5, and IL-13 (Fig 2, D), indicating a regulatory effect of IFN-γ on TH2 cytokine production in this model. Accordingly, the trend toward decreased OVA-specific IgE antibody levels in prenatally A lwoffii F78–exposed mice was also eliminated by anti–IFN-γ treatment (Fig 2, E).

  • View full-size image.
  • Fig 2. 

    Effects of anti−IFN-γ treatment during OVA challenge in offspring of A lwoffii F78−exposed mothers. A, Differential leukocyte numbers in BAL fluids. B, Quantification of inflammation and mucus-producing goblet cells. C, Airway responsiveness to methacholine (MCH) in offspring. D, In vitro TH2 cytokine production by restimulated mononuclear splenocytes. E, OVA-specific serum antibody levels (n = 8 mice per group). ns, Not significant. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001.

Prenatal A lwoffii F78 exposure affects epigenetic modifications within genes of the TH1/TH2 loci 

Epigenetic regulation by histone modification and DNA methylation has been shown to have a crucial role in the development of TH1 and TH2 cells (reviewed by Wilson et al3). ChIP was used to investigate the role of histone modifications at the IFNG promoter, the promoters for IL4 and IL5, and the important TH2 regulatory region conserved noncoding sequence 1 (CNS1) as a possible mechanism underlying the persistent alterations in cytokine production. H4ac (associated with transcriptionally active chromatin) and histone 3 lysine 27 trimethylation (H3K27me3; a marker of inactive chromatin), both of which are known to be modulated during T-cell differentiation,23, 24, 25 were analyzed in CD4+CD25 T cells from prenatally A lwoffii F78– or sham-exposed offspring mice. OVA-sensitized and challenged progeny of sham-exposed mothers (PBS/OVA) showed reduced levels of H4ac at the IFNG promoter compared with PBS-sensitized progeny of sham-exposed mothers (PBS/PBS, Fig 3). This suggests that OVA sensitization/challenge affects the acetylation status of H4 at the IFNG promoter (Fig 3). A lwoffii F78 exposure alone (A lwoffii/PBS) had no effect on H4ac, as shown by a similar H4ac level compared with that of the sham-exposed control group (PBS/PBS). However, in offspring of mothers exposed to A lwoffii F78, the effect of OVA sensitization/challenge on H4ac was prevented. In contrast, no significant changes in H4ac levels were observed between all study groups at the promoter region of the TH1 transcription factor signal transducer and activator of transcription 4, nor were respective mRNA levels significantly changed (see Fig E1 in this article’s Online Repository at www.jacionline.org). Analysis of H4ac within the TH2 locus revealed no differences at the IL5 promoter and the CNS1 region. Only at the IL4 promoter were reduced H4ac levels observed in sensitized/challenged offspring from A lwoffii F78–exposed mothers (Fig 3). In contrast, H3K27me3 was nearly undetectable at all analyzed loci in all study groups, suggesting that this repressive mark was not involved in the regulation of TH1 and TH2 cytokine production in this model.

  • View full-size image.
  • Fig 3. 

    H4 acetylation within the IFNG and IL4 promoters after prenatal A lwoffii F78 exposure. H4ac and H3K27me3 levels within the IFNG, IL4, and IL5 promoters and the CNS1 region were determined by means of ChIP in CD4+CD25 T cells purified from spleens of offspring from A lwoffii F78– or sham-exposed (PBS) mothers. Data represent the results of 2 independent experiments, each with 4 to 8 individually analyzed animals per group. ns, Not significant. ∗∗P < .01.

Additionally, we investigated DNA methylation at the promoters of the IFNG, IL4, and IL5 genes, as well as in the CNS1 region. Six CpG positions known to play a role in IFN-γ expression26 were analyzed, which showed only low site-specific absolute methylation levels (ranging from 11% to 17% in naive mice). Baseline methylation levels were markedly higher within TH2 cytokine promoters, ranging from 29% to 60% for IL4 and from 47% to 100% for IL5, respectively. Prenatal A lwoffii F78 exposure did not, however, induce any changes in the CpG methylation levels at all these sites (see Fig E2 in this article’s Online Repository at www.jacionline.org). In contrast, methylation within the CNS1 region was only discretely affected by prenatal A lwoffii exposure at 3 CpG positions (−8435 [+5% compared with the PBS/OVA group], −8384 [+8%], and −8374 [+11%]; see Fig E2).

Inhibition of histone acetylation by garcinol abolishes A lwoffii F78–mediated asthma protection in the progeny 

In our model the strongest effect of prenatal A lwoffii F78 exposure on epigenetic marks was observed on H4ac at the IFNG promoter. Therefore we explored whether pharmacological inhibition of de novo histone acetylation with garcinol (a polyisoprenylated benzophenone known to inhibit histone acetyltransferases p300 and p300/CBP-associated factor,27 thereby affecting de novo acetylation) could restore the asthmatic phenotype. Initial experiments were performed to exclude possible nonspecific or cytotoxic effects of garcinol treatment on T cells. Ex vivo proliferation of anti-CD3/anti-CD28–stimulated, CFSE-labeled CD4+ T cells isolated from garcinol-treated mice remained completely unaffected. In addition, no effects were observed on in vivo proliferation of CFSE-labeled CD4+ T cells transferred into mice with severe combined immunodeficiency, which were subsequently treated with garcinol (see Fig E3 in this article’s Online Repository at www.jacionline.org). Furthermore, intraperitoneal injection of garcinol was well tolerated by the mice because no changes in behavior, body weight, or coat appearance were observed.

Application of the compound was carried out in a time period that has been identified by the IFN-γ–blocking experiment. This is further supported by the observation that prenatal exposure with A lwoffii F78 did not affect the sensitization to OVA but counteracts the development of airway inflammation and airway hyperreactivity triggered by OVA challenge.13 Garcinol treatment of sham-sensitized progeny from PBS-exposed mothers reduced H4ac levels at the IFNG promoter (see Fig E4 in this article’s Online Repository at www.jacionline.org). Already low levels of H4ac in sensitized/challenged progeny from sham-exposed mothers were not further affected by garcinol treatment. However, garcinol treatment of progeny from A lwoffii F78–exposed mothers significantly prevented the A lwoffii F78–induced protection against the loss of H4ac at this locus. In contrast, garcinol treatment did not affect H4ac levels at the IL4 promoter, the IL5 promoter, and CNS1 (Fig 4, A).

  • View full-size image.
  • Fig 4. 

    Effects of garcinol treatment during OVA challenge on H4 acetylation at the IFNG promoter of CD4+CD25 splenic T cells and asthma protection by prenatal A lwoffii F78 exposure. A, H4ac within the IFNG and IL4 promoters and CNS1 (for control groups, see Fig E4). B, Differential leukocyte numbers in BAL fluid. C, Quantification of airway inflammation and mucus-producing goblet cells. D, Airway responsiveness to aerosolized methacholine (MCH). E, In vitro cytokine production by restimulated splenocytes. Gar, Garcinol. Data represent the results of 2 independent experiments, each with 4 to 8 individually analyzed animals per group. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001.

Consequently, garcinol treatment resulted in significantly reduced IFN-γ levels in anti-CD3/anti-CD28–stimulated splenic MNCs accompanied by increased IL-4, IL-5, and IL-13 production (Fig 4, E). Moreover, the asthmatic phenotype was fully restored by garcinol treatment of the progeny of A lwoffii F78–exposed mothers, as indicated by a significant influx of eosinophils into the airway lumen (Fig 4, B), marked inflammatory cell accumulation in the lung tissue and goblet cell hyperplasia (Fig 4, C), and development of airway hyperreactivity to aerosolized methacholine (Fig 4, D). Garcinol treatment has no influence on the asthmatic phenotype of prenatally PBS-exposed animals (data not shown).

Back to Article Outline

Discussion 

In this study we provide evidence that epigenetic regulation plays an important role in transmaternal asthma protection. This protection is dependent on the production of IFN-γ, as indicated by the abolishment of asthma protection after functional blockade of this cytokine by mAb treatment. Focusing on cytokine genes of the adaptive immune response, we discovered significant changes in H4 acetylation at the IFNG promoter and the IL4 promoter, which were positively associated with IFN-γ and IL-4 protein levels. In contrast, H4 acetylation was not changed at the IL5 promoter and at the genomic enhancer region CNS1 of the TH2 cytokine cluster, nor was CpG methylation significantly affected at IFNG, as well as at the TH2 locus.

IFN-γ is a potent suppressor of TH2-driven allergic immune responses counteracting airway hyperresponsiveness, airway eosinophilia, and mucus production.21, 22, 28 In mice and human subjects, a number of studies have provided evidence for the pivotal role of IFN-γ in allergy protection (reviewed by Vuillermin et al29). T cells from subjects at risk of atopic disease generally produce lower IFN-γ levels.30 Accordingly, recent epidemiologic studies demonstrate that maternal farm exposure is significantly associated with a higher capacity of cord blood–derived MNCs to produce IFN-γ,31 supporting a direct influence of environmental factors on prenatal T-cell maturation. This is in agreement with our findings in a murine model and illustrates the importance of the adaptive immune response in the regulation of transmaternal asthma protection.

Epigenetic processes are a consequence of complex gene-environment interactions that are known to modulate the phenotype without affecting the genotype. In this regard epigenetic processes contribute to the plasticity of gene expression and consequently are crucial for developmental processes and cell differentiation, including maturation of TH cells.26, 32, 33, 34 Both human and murine studies provide strong evidence for a regulatory role of epigenetic processes within the genomic locus on the production of IFN-γ.5, 23, 26, 35 In particular, in vitro differentiation of murine unmethylated naive TH0 cells did not influence CpG methylation under TH1-polarizing conditions, whereas TH2 polarization was associated with hypermethylation of the respective CpG sites.26 In our experiments no differences between treatment groups were observed with regard to CpG methylation levels within the proximal IFNG promoter.

In contrast, our data point toward a role of H4 acetylation in transcriptional control of the IFNG locus. H4 acetylation is an important mark for an open chromatin structure, and indeed, the changes observed in terms of H4 acetylation at this promoter were positively associated with changes in IFN-γ protein production. Animals were treated with garcinol, a known inhibitor of histone acetyltransferases p300 and p300/CBP-associated factor, to further investigate the role of histone acetylation.27, 36 Analysis of the H4 acetylation levels at the IFNG promoter indicated that garcinol treatment prevented the A lwoffii F78–induced increases in de novo acetylation in this promoter. Furthermore, the A lwoffii F78–mediated prevention of the asthmatic phenotype was abolished in these animals. These data suggest that histone acetylation at the IFNG gene promoter might represent an important mechanism in the process of asthma protection by microbial exposures in this model. However, because of the limitations of the model, we cannot rule out that epigenetic modifications of further immune-regulatory molecules might also be involved in the multifactorial process of asthma development and protection.

The reduced production of the TH2 cytokines IL-4, IL-5, and IL-13 observed in the OVA-sensitized and challenged animals derived from A lwoffii F78–treated mother mice is most likely due to a regulatory effect of the high levels of IFN-γ in these animals and might be linked to the observation that acetylation at the H4 histone of the IL-4 promoter is decreased. It is well known that IFN-γ has a strong inhibitory effect on the development and activation of TH2 cells. Analyses of CpG methylation levels of the promoters of IL-4 and IL-5 provided no evidence for a role of CpG methylation in this context. Only in the genomic TH2 enhancer region CNS1 was an effect on CpG methylation observed in some of the 13 investigated CpG sites. These changes in methylation levels might further support the suppression of TH2 cytokine protein production. Therefore protection against loss of H4 acetylation in the IFNG promoter together with increases in CNS1 CpG methylation could work together in this context.

It is well known that epigenetic processes are critical in the regulation of IFN-γ production in human subjects and mice.23, 25, 26, 35 Here we demonstrate an important role for H4ac in transcriptional control of the IFNG locus. H4ac is an important marker for an open chromatin structure, and indeed, the changes observed in terms of H4ac at the IFNG promoter positively correlate with changes in IFN-γ protein production.

It still remains unclear which signals are directly responsible for activation of histone-modifying enzymes, DNA methyltransferases, or both.37, 38, 39 It has been suggested that inflammatory conditions on several levels, including the production of IL-6, reactive oxygen species, and IκB kinase α activation, might be involved in the activation of these enzymes. In particular, IL-6 could be a relevant mediator of the observed protection in our model because we have recently shown that the A lwoffii F78–mediated effects are dependent on maternal Toll-like receptor recognition of this microbe, subsequently leading to a sustained release of IL-6.13

This is the first study indicating that asthma protection achieved by maternal exposure to microbes is associated with epigenetic regulation in the offspring. There are, of course, additional environmental factors that might exert their effects on the epigenetic level as well. Prenatal methyl-donor–rich diet,40 exposure to airborne polycyclic aromatic hydrocarbons,41 or diesel exhaust particles42 were shown to be associated with changes in DNA methylation levels, the latter at the IFNG promoter. Here we observe for the first time that the gram-negative bacterium A lwoffii F78 triggers characteristic alterations in histone modification at specific genomic loci. This is associated with altered cytokine production levels and subsequent prevention of the asthmatic phenotype. Those data obtained in animal models are now the foundation to translate these observations into the human situation. Nevertheless, our data support the concept that maternal exposure plays an important role in allergy and asthma prevention of the next generation and that epigenetic regulation in the progeny is an important mechanism. Such epigenetic effects might be amenable to interventions to prevent asthma development.

Clinical implications

Epigenetic modulation induced by prenatal exposure to microbes represents an important mechanism for the prevention of allergy and asthma in the offspring.

Back to Article Outline

 

We thank T. Ruppersberg, F. Dederichs, M. Schimmel, J.-C. Rauch, and A. P. Spies-Naumann for excellent technical assistance. We also thank M. Lohoff for helpful discussions.

Back to Article Outline

Methods 

Preparation of garcinol 

Garcinol was reconstituted in dimethyl sulfoxide at a concentration of 24 mg/mL and stored at −20°C. Before intraperitoneal treatment of the animals, the stock solution was further diluted 1:600 in PBS, resulting in a final concentration of 40 μg/mL. Control animals received PBS/0.16% (vol/vol) dimethyl sulfoxide.

Assessment of airway reactivity 

Lung function analysis was performed 24 hours after the last aerosol challenge by using noninvasive head-out body plethysmography, as previously described,E1 a method that was shown to directly correlate with invasive lung function measurements of lung resistance.E2 Briefly, bronchial responsiveness was determined as changes in midexpiratory airflow in response to consecutive exposures to increasing concentrations (3, 6, 12.5, 25, 50, 75, 100, and 125 mg/mL) of aerosolized β-methacholine (Sigma). The methacholine concentration that induced a 50% reduction of baseline midexpiratory airflow was defined as MCH50.

Principal comparison of noninvasive head-out body plethysmography with invasive Flexivent lung function analysis in our laboratory revealed concordance (data not shown).

BAL and differential cell counts 

BAL was performed as described previously,E1 with the exception that lavage was performed only once with a volume of 1 mL. An automated Casy TT cell counter (Schaerfe Systems, Reutlingen, Germany) was used to determine total leukocyte cell counts. For differential cell count analysis, cytospin preparations were prepared, fixed, and stained with Diff-Quick (Merz & Dade AG, Dudingen, Switzerland).

Lung histology and quantitative morphologic analysis of mucin production 

Directly after BAL, lungs were fixed with 6% paraformaldehyde. Lung tissues were embedded into paraffin, and 3-μm sections were stained with periodic acid–Schiff. Goblet cell metaplasia and the volume of epithelial mucin per surface area of the airway epithelial basal membrane was determined as described previously.E3 Inflammatory scores were quantified as follows: 0, normal; 1, few inflammatory cells; 2, 1 to 2 cell layers of inflammatory cells; and 3, 3 or more cell layers of inflammatory cells.

Measurement of proliferation 

MNCs from garcinol-treated animals were labeled with 1 μmol/L CFSE (Molecular Probes, Invitrogen) for 15 minutes at 37°C (according to the manufacturer’s instructions) before stimulation with anti-CD3 and anti-CD28 to assess ex vivo proliferative capacity of cells. After 72 hours, cells were harvested and stained with anti-CD4–allophycocyanin (BD), and proliferation was determined by means of flow cytometry.

CD4+ T cells were isolated from spleens of BALB/c mice by means of MACS, as recommended by the manufacturer (Miltenyi Biotec), and labeled with 1 μmol/L CFSE to assess the in vivo proliferative capacity of cells. Cells (1 × 107) were transferred by means of intravenous injection into BALB/cscid mice. Recipients were treated every other day with 0.2 mg/kg garcinol intraperitoneally. At day 8, proliferation of CFSE-labeled CD4+ T cells from the spleen was determined by means of flow cytometry.

Preparation and bisulfite conversion of genomic DNA, PCR, and pyrosequencing 

CD4+CD25 T cells were isolated from splenic MNCs by means of MACS, as recommended by the manufacturer (Miltenyi Biotec); resuspended in ATL buffer (Qiagen); and incubated with proteinase K (Sigma) at 37°C for 1 hour. Proteinase K was deactivated by means of incubation at 95°C for 15 minutes, and genomic DNA was stored at −80°C.

Bisulfite conversion of genomic DNA was performed as described elsewhere.E4 PCR products were generated in a 50-μL reaction volume with 10 pmol of forward and reverse primer and HotstarTaq PCR Master Mix (Qiagen). Template preparation was performed as described previously by Tost and Gut.E5 Pyrosequencing was performed with the PyroMark ID System (Biotage AB) and sequencing primers (see below). The position of CpG sites within the genomic sequence was determined in comparison with the transcription start of published full-length mRNA sequences NM_008337 (IFNG), NM_010558 (IL5), and NM_021283 (IL4). The IL4 transcription start site was used for numbering of CpGs within CNS1. Primers sequence are shown in Table E2.

  • View full-size image.
  • Fig E1. 

    H4 acetylation within the STAT-4 promoter after prenatal A lwoffii F78 exposure. H4ac and H3K27me3 levels within the STAT-4 promoter were determined by means of ChIP in CD4+ CD25+ T cells purified from spleens of offspring from A lwoffii F78- or sham-exposed (PBS) mothers. Data represent the results of 2 independent experiments, each with 4 to 8 individually analyzed animals per group. ns, Not significant.

  • View full-size image.
  • Fig E2. 

    Modulation of DNA methylation within CNS1 in splenic CD4+CD25 T cells from offspring after prenatal A lwoffii F78 exposure. Positions of CpG sites correspond to their positions upstream of the transcription start site of annotated sequence NM_008337 for IFNG (A), NM_010558 (IL5), and NM_021283 (IL4) for IL4 and CNS1 (B). Data represent results of 2 independent experiments, each with 4 to 8 individually analyzed animals per group. ∗P < .05, ∗∗P < .01.

  • View full-size image.
  • Fig E3. 

    T-cell activation and proliferation after garcinol treatment. A, Ex vivo proliferation of splenic T cells of garcinol- and PBS-treated mice determined by means of CD4+ and CFSE labeling and subsequent FACS analysis. B, In vivo proliferation of splenic CFSE-labeled CD4+ T cells transferred from garcinol- or PBS-treated mice intravenously into BALB/cscid mice determined at day 8 by means of FACS analysis. Data are from 1 representative mouse per group. Two independent experiments were performed, each with 2 to 4 individually analyzed animals per group.

  • View full-size image.
  • Fig E4. 

    Modulation of H4 acetylation at the IFNG promoter by using the histone acetyltransferase inhibitor garcinol (control groups). H4ac levels within the IFNG and IL4 promoter and CNS1 in CD4+CD25 splenic T cells from offspring treated with garcinol before each OVA challenge were analyzed by means of ChIP. Data represent the results of 2 independent experiments, each with 4 to 8 individually analyzed animals per group. ns, Not significant. Respective data of experimental groups are provided in Fig 4. ns, Not significant. ∗∗P < .01.

Table E1. Asthma-protective effect of different bacterial strains
Change in % compared with the sham-treated OVA group
Exposure to:Acinetobacter lwoffii F78E5Lactococcus lactis G121E6Bacillus licheniformis 467E7
BAL§
Leukocytes−34 ± 5†−36 ± 9†−31 ± 16
Eosinophils−92 ± 2‡−88 ± 4‡−89 ± 6‡
Lymphocytes+120 ± 31∗+40 ± 26+7 ± 27
Macrophages+36 ± 9+36 ± 21+69 ± 15
Airway reactivity#+144 ± 11∗+116 ± 13∗+53 ± 23
Change in % compared with the sham-treated OVA group
Maternal exposure to:A lwoffii F78E4Lactococcus lactis G121 (unpublished data)LPSE8
BAL§
Leukocytes−56 ± 12∗−11 ± 13−72 ± 5∗
Eosinophils−55 ± 11∗−8 ± 16−63 ± 7†
Lymphocytes−59 ± 9∗+3 ± 17−55 ± 15
Macrophages+31 ± 23−31 ± 30−55 ± 5∗
Immunoglobulins
Anti-OVA IgE−31 ± 7+1 ± 1−66 ± 12∗
Anti-OVA IgG1−25 ± 16−7 ± 6−94 ± 3‡
Anti-OVA IgG2a−18 ± 28+39 ± 30+43 ± 41
Cytokines in spleen
IFN-γ+26 ± 7∗+17 ± 12−27 ± 24
IL-5−54 ± 8†−40 ± 23−75 ± 5†
Airway reactivity#+64 ± 14†+27 ± 12−20 ± 27
Inflammation score∗∗−33 ± 5∗−15 ± 11Not done

The table reviews previously published data as indicated by the mentioned references. The top panels show that female BALB/c mice were intranasally exposed to PBS (control), A lwoffii F78, L lactis G121, or B licheniformis starting 10 days before sensitization until aerosol challenge. After challenge, the asthmatic phenotype was analyzed. The bottom panels show female BALB/c mice were intranasally exposed to PBS (control), A lwoffii F78, or L lactis G121 before and during pregnancy. LPS application was performed intraperitoneally before mating and intranasally during pregnancy. Offspring were sensitized to OVA and OVA aerosol challenged, and the asthmatic phenotype was analyzed.

Means ± SEs are shown with significances for PBS/OVA versus bacterium/OVA: ∗P < .05, †P < .01, and ‡P < .001.

§Numbers of total leukocytes, eosinophils, macrophages, and lymphocytes in BAL fluid.

Concentration of anti-OVA IgE, anti-OVA IgG1, and anti-OVA-IgG2a in serum of offspring.

Cytokine production of anti-CD3/anti-CD28–stimulated MNCs from spleens of offspring.

#Airway responsiveness to methacholine measured by means of head-out body plethysmography, as described in the Methods section. Shown is the methacholine concentration that causes a 50% reduction in baseline midexpiratory airflow.

∗∗Quantification of inflammation in airways as described in the Methods section.

Table E2. Primer sequences
Bisulfite PCR5′-3′
Py–IFN-γ
sGGT TTG AGA AGT TTA AGA GTT TTT TTA
asBiotin - CCT ACA CCT CTC TAA CTT CCA ATT TTA TAC CTA ATC
Py–CNS-1
sTAT AAG GGT TGT AGG AAG AGT AAT GTA GTT TTT ATA T
asBiotin - CAC TTT AAA CTA ATC AAA CCT AAA ACT ATA TCC ATA
Py–IL-4
sGTT AAA GTT TTA TTT TAT GGT TTT GTT TGT TTT AT
asBiotin - ACA AAT AAA TTT TCC TAT AAA ATC AAA CCA ATT AA
Py–IL-5
sGGG GAT AAA AAA GAA GGT GTT TAA GAA AAG T
asBiotin - AAA CAC TCA AAT ACA AAA ACA TCC TTC TCA TAA CT
Pyrosequencing5′- 3′
IFN-γ seq 1ATT TTA TAA GAA TGG TAT AGG TG
IFN-γ seq 2AAA ATT AAA AAA AAA TTT GTG
CNS-1 seq 1AAT GTA GTT TTT ATA TAT TGG TTT AT
CNS-1 seq 2.1TTG AGA GGG GAT TAT TTT TTA T
CNS-1 seq 3.1TAT GGG GTT TTT TTT GGT TG
IL-4 seq 2TTT TTT TGA TAT TAT TTT GTT
IL-5 seq 1AAG AAG GTG TTT AAG AAA AG
IL-5 seq 2TTT TTT AGA GAG AGA ATA AAT TG
ChIP5′- 3′
Ch–IFN-γ
sCAT ACC CTT TCC TTG CTT TTC
asTTG TGG GAT TCT CTG AAA GCA
Ch–CNS-1
sGGG AGT TTC TTA GGC CCT CT
asCCC CCT CTC ACT GTG AAA AC
Ch–IL-4
sTCT GCC TCC ATC ATC CTT CT
asACA CCA TAA TCG GCC TTT CA
Ch–IL-5
sACC CTG AGT TTC AGG ACT CG
asTCC CCA AGC AAT TTA TTC TCT C
Ch-STAT4
sAGA GGA ATG GCG TCA GCG GC
asACT GAG CTA GCA GAT GCC GGA T
Quantitative PCR5′- 3′
IFN-γ
sGCG TCA TTG AAT CAC ACC TG
asTGA GCT CAT TGA ATG CTT GG
IL-4
sTCA ACC CCC AGC TAG TTG TC
asTGT TCT TCG TTG CTG TGA GG
IL-5
sAGC ACA GTG GTG AAA GAG ACC T
asTCC AAT GCA TAG CTG GTG ATT T
IL-13
sCCA TCC CAT CCC TAC AGA AA
asATA GGC AGC AAA CCA TGT CC
CD3d
sACA CTC AAC TTG GGC AAA GG
asCAG AGT TGC GAT GAG GTC AA
STAT4
sACT ACA GCT CCC AGC CGT GC
asCCG TGG AAT CGC TTC GGA TTG TT

as, Anti-sense s, sense STAT4, signal transducer and activator of transcription 4.

Back to Article Outline

References 

  1. Vercelli D. Gene-environment interactions: the road less traveled by in asthma genetics. J Allergy Clin Immunol. 2009;123:26–27
  2. Martino DJ, Prescott SL. Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy. 2010;65:7–15
  3. Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol. 2009;9:91–105
  4. Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med. 2008;177:567–573
  5. White GP, Hollams EM, Yerkovich ST, Bosco A, Holt BJ, Bassami MR, et al. CpG methylation patterns in the IFNgamma promoter in naive T cells: variations during Th1 and Th2 differentiation and between atopics and non-atopics. Pediatr Allergy Immunol. 2006;17:557–564
  6. Riedler J, Braun-Fahrlander C, Eder W, Schreuer M, Waser M, Maisch S, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001;358:1129–1133
  7. von Mutius E, Radon K. Living on a farm: impact on asthma induction and clinical course. Immunol Allergy Clin North Am. 2008;28:631–647ix-x
  8. Debarry J, Garn H, Hanuszkiewicz A, Dickgreber N, Blumer N, von Mutius E, et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol. 2007;119:1514–1521
  9. Debarry J, Hanuszkiewicz A, Stein K, Holst O, Heine H. The allergy-protective properties of Acinetobacter lwoffii F78 are imparted by its lipopolysaccharide. Allergy. 2010;65:690–697
  10. Blumer N, Sel S, Virna S, Patrascan CC, Zimmermann S, Herz U, et al. Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy. 2007;37:348–357
  11. Blumer N, Herz U, Wegmann M, Renz H. Prenatal lipopolysaccharide-exposure prevents allergic sensitization and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy. 2005;35:397–402
  12. Vogel K, Blumer N, Korthals M, Mittelstadt J, Garn H, Ege M, et al. Animal shed Bacillus licheniformis spores possess allergy-protective as well as inflammatory properties. J Allergy Clin Immunol. 2008;122:307–312
  13. Conrad ML, Ferstl R, Teich R, Brand S, Blumer N, Yildirim AO, et al. Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. J Exp Med. 2009;206:2869–2877
  14. Koya T, Takeda K, Kodama T, Miyahara N, Matsubara S, Balhorn A, et al. RANTES (CCL5) regulates airway responsiveness after repeated allergen challenge. Am J Respir Cell Mol Biol. 2006;35:147–154
  15. Hoymann HG. Invasive and noninvasive lung function measurements in rodents. J Pharmacol Toxicol Methods. 2007;55:16–26
  16. Neuhaus-Steinmetz U, Glaab T, Daser A, Braun A, Lommatzsch M, Herz U, et al. Sequential development of airway hyperresponsiveness and acute airway obstruction in a mouse model of allergic inflammation. Int Arch Allergy Immunol. 2000;121:57–67
  17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408
  18. Waterland RA, Lin JR, Smith CA, Jirtle RL. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet. 2006;15:705–716
  19. Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc. 2007;2:2265–2275
  20. Wagner S, Weber S, Kleinschmidt MA, Nagata K, Bauer UM. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. J Biol Chem. 2006;281:27242–27250
  21. Busse WW, Rosenwasser LJ. Mechanisms of asthma. J Allergy Clin Immunol. 2003;111(suppl):S799–S804
  22. Dow SW, Schwarze J, Heath TD, Potter TA, Gelfand EW. Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. Hum Gene Ther. 1999;10:1905–1914
  23. Schoenborn JR, Dorschner MO, Sekimata M, Santer DM, Shnyreva M, Fitzpatrick DR, et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat Immunol. 2007;8:732–742
  24. Fields PE, Kim ST, Flavell RA. Cutting edge: changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1/Th2 differentiation. J Immunol. 2002;169:647–650
  25. Chang S, Aune TM. Dynamic changes in histone-methylation “marks” across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat Immunol. 2007;8:723–731
  26. Jones B, Chen J. Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J. 2006;25:2443–2452
  27. Balasubramanyam K, Altaf M, Varier RA, Swaminathan V, Ravindran A, Sadhale PP, et al. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem. 2004;279:33716–33726
  28. Lack G, Renz H, Saloga J, Bradley KL, Loader J, Leung DY, et al. Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J Immunol. 1994;152:2546–2554
  29. Vuillermin PJ, Ponsonby AL, Saffery R, Tang ML, Ellis JA, Sly P, et al. Microbial exposure, interferon gamma gene demethylation in naive T-cells, and the risk of allergic disease. Allergy. 2009;64:348–353
  30. Rowe J, Heaton T, Kusel M, Suriyaarachchi D, Serralha M, Holt BJ, et al. High IFN-gamma production by CD8+ T cells and early sensitization among infants at high risk of atopy. J Allergy Clin Immunol. 2004;113:710–716
  31. Pfefferle PI, Buchele G, Blumer N, Roponen M, Ege MJ, Krauss-Etschmann S, et al. Cord blood cytokines are modulated by maternal farming activities and consumption of farm dairy products during pregnancy: the PASTURE Study. J Allergy Clin Immunol. 2010;125:108–115
  32. Young HA, Ghosh P, Ye J, Lederer J, Lichtman A, Gerard JR, et al. Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene. J Immunol. 1994;153:3603–3610
  33. Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol. 2003;4:616–623
  34. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?. Nat Rev Immunol. 2009;9:83–89
  35. White GP, Watt PM, Holt BJ, Holt PG. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD. J Immunol. 2002;168:2820–2827
  36. Mantelingu K, Reddy BA, Swaminathan V, Kishore AH, Siddappa NB, Kumar GV, et al. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol. 2007;14:645–657
  37. Hodge DR, Peng B, Cherry JC, Hurt EM, Fox SD, Kelley JA, et al. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res. 2005;65:4673–4682
  38. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, et al. Impact of inflammation on epigenetic DNA methylation—a novel risk factor for cardiovascular disease?. J Intern Med. 2007;261:488–499
  39. Yang SR, Valvo S, Yao H, Kode A, Rajendrasozhan S, Edirisinghe I, et al. IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung. Am J Respir Cell Mol Biol. 2008;38:689–698
  40. Hollingsworth JW, Maruoka S, Boon K, Garantziotis S, Li Z, Tomfohr J, et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest. 2008;118:3462–3469
  41. Perera F, Tang WY, Herbstman J, Tang D, Levin L, Miller R, et al. Relation of DNA methylation of 5’-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS One. 2009;4:e4488
  42. Liu J, Ballaney M, Al Alem U, Quan C, Jin X, Perera F, et al. Combined inhaled diesel exhaust particles and allergen exposure alter methylation of T helper genes and IgE production in vivo. Toxicol Sci. 2008;102:76–81

Back to Article Outline

References 

  1. Neuhaus-Steinmetz U, Glaab T, Daser A, Braun A, Lommatzsch M, Herz U, et al. Sequential development of airway hyperresponsiveness and acute airway obstruction in a mouse model of allergic inflammation. Int Arch Allergy Immunol. 2000;121:57–67
  2. Hoymann HG. Invasive and noninvasive lung function measurements in rodents. J Pharmacol Toxicol Methods. 2007;55:16–26
  3. Conrad ML, Ferstl R, Teich R, Brand S, Blumer N, Yildirim AO, et al. Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. J Exp Med. 2009;206:2869–2877
  4. Waterland RA, Lin JR, Smith CA, Jirtle RL. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet. 2006;15:705–716
  5. Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc. 2007;2:2265–2275
  6. Debarry J, Garn H, Hanuszkiewicz A, Dickgreber N, Blumer N, von Mutius E, et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol. 2007;119:1514–1521
  7. Vogel K, Blumer N, Korthals M, Mittelstadt J, Garn H, Ege M, et al. Animal shed Bacillus licheniformis spores possess allergy-protective as well as inflammatory properties. J Allergy Clin Immunol. 2008;122:307–312
  8. Blumer N, Herz U, Wegmann M, Renz H. Prenatal lipopolysaccharide-exposure prevents allergic sensitization and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy. 2005;35:397–402

 Supported by the Deutsche Forschungsgemeinschaft (SFB/TR22); Stiftung P.E. Kempkes, Marburg (10/07); and the LOEWE excellence centre UGMLC (Universities of Gießen and the Marburg Lung Centre).

 Disclosure of potential conflict of interest: E. von Mutius has consulted for GlaxoSmithKline, Novartis, and Mundipharma and has received research support from Airsonett AB and the German Research Foundation. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(11)00673-7

doi:10.1016/j.jaci.2011.04.035

The Journal of Allergy and Clinical Immunology
Volume 128, Issue 3 , Pages 618-625.e7, September 2011